loser
- KalVista Pharmaceuticals, Inc. CALV Shares fell 58.9% to close at $5.85 on Tuesday after the company announced it had completed the Phase 2 KOMPLETE clinical trial of KVD824 in preventing attacks in people with hereditary angioedema.
- Lang, Inc MANDATORY fell 40.3% to close at $0.2390 after rising 167% on Monday.
- FaZe Holdings Inc. FAZE fell 39.1% to close at $4.96 after the Company filed a motion to issue up to approximately 5.92 million common shares, resell up to approximately 64 million common shares and resell approximately 173,000 warrants.
- FedNat holding company FNHC Shares fell 37% to close at $0.2963 after rising around 309% on Monday.
- Verastem, Inc. VSTM fell 34.6% to close at $0.5718 after the company announced clinical trials of RAMP VS-6766 and company updates.
- Rallybio Corporation RLYB fell 27.6% to close at $10.76. Rallybio recently announced preliminary results from its ongoing phase 1b proof of concept study of RLYB212 in the prevention of fetal and neonatal alloimmune thrombocytopenia.
- Atlis Motor Vehicles, Inc. AMV fell 22.6% to close at $14.30 after falling over 9% on Monday.
- AX, Inc. AXTI fell 21.1% to close at $5.53 after the company cut preliminary third-quarter sales guidance below estimates.
- Cryo-Cell International, Inc. CCEL fell 18.5% to $5.30.
- Wearable Devices Ltd. WLDS fell 17.6% to close at $1.08.
- COMSovereign Holding Corp. COMS fell 17.3% to $0.0630.
- Powerbridge Technologies Co.,Ltd. PBTS declined 17% to close at $0.3303.
- Mondee Holdings, Inc. MOON fell 15.4% to close at $7.44.
- Join Biopharma Holdings Limited CNTB fell 15.3% to close at $1.11. Connect Biopharma announced top-line results for the primary analysis population of the pivotal study of CBP-201 in patients with moderate to severe atopic dermatitis (AD) in China.
- Athersys, Inc. ATHX declined 13.7% to close at $1.89.
- Cocrystal Pharma, Inc. COCP fell 13.7% to settle at…
